MYC and cancer: In addition, PZH treatment can upregulate the expression of miR-22, a tumor supressor miRNA, and downregulate the expression of its target gene c-MYC, suggesting that PZH could also overcome chemo-resistance in cancer cells by increasing miR-22 expression and, possibly, by reversing the imbalance between proliferation and apoptosis [71].